Literature DB >> 12298423

Toxicology in the Old Testament. Did the High Priest Alcimus die of acute aconitine poisoning?

Ferdinand P Moog1, Axel Karenberg.   

Abstract

The Bible contains several interesting contributions to the history of neurology, as is the case of the High Priest Alkimos, who died suddenly in 159 BC. He was regarded as a stereotypical stroke victim for a long time. The reports on his death in the Septauginta and the later 'Jewish Antiquities' of Flavius Josephus present some typical symptoms of stroke (collapse, loss of speech and death within a short time), but they also describe severe pains, which are very unusual among patients with stroke. Similar symptoms can be found in the case of the Roman emperor Claudius, who was poisoned by his spouse Agrippina. It was thought that she used aconitine, an ingredient of the monkshood plant (Aconitum napellus L.), which imitates an apoplectic insult, but also causes vehement pains. It was therefore possible that something similar had happened to Alkimos, as aconitine was a common poison in ancient times and the surroundings of his death may confirm the suspicion. Reigning during a time of great upheaval, Alkimos was able to maintain his high office chiefly because of the help of the Seleucides. He has just begun construction work on the temple of Jerusalem, an order, which was regarded as a sacrilege by his foes. This impression was enhanced by his subsequent illness which could be considered as a divine punishment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12298423     DOI: 10.1007/bf03256190

Source DB:  PubMed          Journal:  Adverse Drug React Toxicol Rev        ISSN: 0964-198X


  2 in total

1.  Aconitine involvement in an unusual homicide case.

Authors:  An A Van Landeghem; Els A De Letter; Willy E Lambert; Carlos H Van Peteghem; Michel H A Piette
Journal:  Int J Legal Med       Date:  2006-10-05       Impact factor: 2.791

2.  Newer insights to the neurological diseases among biblical characters of old testament.

Authors:  Stephen K Mathew; Jeyaraj D Pandian
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.